Authors: Woitge, HW Horn, E Keck, AV Auler, B Seibel, MJ Pecherstorfer, M

Citation: Hw. Woitge et al., Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis, CLIN CHEM, 47(4), 2001, pp. 686-693

Authors: Woitge, HW Pecherstorfer, M Horn, E Keck, AV Diel, IJ Bayer, P Ludwig, H Ziegler, R Seibel, MJ

Citation: Hw. Woitge et al., Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma, BR J CANC, 84(3), 2001, pp. 344-351

Authors: Pecherstorfer, M Jilch, R Sauty, A Horn, E Keck, AV Zimmer-Roth, I Thiebaud, D

Citation: M. Pecherstorfer et al., Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations, J BONE MIN, 15(1), 2000, pp. 147-154

Authors: Woitge, HW Pecherstorfer, M Li, YM Keck, AV Horn, E Ziegler, R Seibel, MJ

Citation: Hw. Woitge et al., Novel serum markers of bone resorption: Clinical assessment and comparisonwith established urinary indices, J BONE MIN, 14(5), 1999, pp. 792-801

Authors: Zojer, N Keck, AV Pecherstorfer, M

Citation: N. Zojer et al., Comparative tolerability of drug therapies for hypercalcaemia of malignancy, DRUG SAFETY, 21(5), 1999, pp. 389-406